BioCentury
ARTICLE | Company News

Glycotope, Octapharma deal

October 19, 2015 7:00 AM UTC

Glycotope granted Octapharma exclusive, worldwide rights to develop and commercialize preclinical human blood coagulation factors based on Glycotope’s GlycoExpress platform. Glycotope’s technology con...